Effect of SRT2104 on Endotoxin-induced Inflammation

NCT01014117 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Sepsis

Interventions

DRUG: Placebo
DRUG: SRT2104

Sponsor

GlaxoSmithKline